5H1D
Crystal structure of C-terminal of RhoGDI2
5H1D の概要
| エントリーDOI | 10.2210/pdb5h1d/pdb |
| 分子名称 | Rho GDP-dissociation inhibitor 2 (2 entities in total) |
| 機能のキーワード | signaling protein |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Cytoplasm, cytosol : P52566 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 16427.71 |
| 構造登録者 | |
| 主引用文献 | Liu, J.,Gao, J.,Li, F.,Ma, R.,Wei, Q.,Wang, A.,Wu, J.,Ruan, K. NMR characterization of weak interactions between RhoGDI2 and fragment screening hits. Biochim. Biophys. Acta, 1861:3061-3070, 2017 Cited by PubMed Abstract: The delineation of intrinsically weak interactions between novel targets and fragment screening hits has long limited the pace of hit-to-lead evolution. Rho guanine-nucleotide dissociation inhibitor 2 (RhoGDI2) is a novel target that lacks any chemical probes for the treatment of tumor metastasis. PubMed: 27721047DOI: 10.1016/j.bbagen.2016.10.003 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.494 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






